Intriguingly, collagen hydrolysates (CH) have recently be shown to provide benefits for patients with type 2 diabetes mellitus (T2DM), including the promotion of glucagon—like peptide 1 (GLP-1) secretion and the inhibition of dipeptidyl peptidase IV activity [10,11]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.